Llwytho...
Priorities for developing respiratory syncytial virus vaccines in different target populations
The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the virus in the RSV season after vaccination. Recent...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Sci Transl Med |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7613568/ https://ncbi.nlm.nih.gov/pubmed/32188721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aax2466 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|